Procedures & recovery · patient guide

AFP blood test in China at a glance

An AFP blood test measures alpha-fetoprotein in a blood sample. On its own it cannot confirm or exclude liver cancer, and it is interpreted alongside liver imaging, other blood tests, your history and the reason the test was ordered. In China, the practical decision is usually who should order and interpret it, and which records the reviewing clinician needs.

Go to the practical guidance ↓
AI illustration: A female doctor consulting with an older male patient in a clinic room.
AI-generated illustration for care planning; not a photograph of a real patient, clinician or hospital, and not a diagnostic image.
In this guide

What the AFP test actually measures

Alpha-fetoprotein is a protein normally produced in early fetal development. After birth, levels are generally low in healthy adults. A laboratory measures the amount in a blood sample and reports it against a reference range that the laboratory itself defines, so the numbers on one report cannot simply be compared with another laboratory's range.

The test is not a stand-alone cancer screen. It is used in defined clinical situations, most recognisably as part of monitoring people with known chronic liver disease or as one component of liver cancer assessment and surveillance. It can also be raised in some other conditions and in pregnancy, which is why a result is read in the context of the individual rather than as a verdict.

For an international patient, the useful question is not only 'what is my AFP level' but 'what is this test being used to look for, and what else does the clinician need to interpret it'. A single number without that context can create anxiety or false reassurance in equal measure.

Why one AFP result cannot answer the cancer question

AFP is a non-specific marker. A raised value does not by itself establish liver cancer, and a value within the reference range does not exclude it. Clinicians interpret AFP together with liver ultrasound or other imaging, liver function tests, hepatitis status, symptoms and the person's history. In some situations AFP is normal even when disease is present, and in others it is raised for reasons unrelated to cancer.

This is why a report that says only 'AFP: value' is a starting point, not a conclusion. The reviewing clinician needs to know which laboratory performed the test, the reference range used, whether the sample was taken fasting or not, and what other tests were done at the same time. If you already have imaging or earlier AFP results, the trend over time can matter more than a single reading.

Patients sometimes ask whether an AFP test in a Chinese hospital is 'accurate'. The more useful question is whether the laboratory is appropriately accredited and whether the ordering clinician will interpret the result in the right clinical context. Ask the hospital how results are reported and whether an English-language report is available; do not assume a universal format.

Who should order and interpret the test

An AFP test is normally requested by a clinician who has a specific reason: known chronic hepatitis B or C, cirrhosis, a liver lesion under assessment, or follow-up of a previously treated liver cancer. Buying the test as a stand-alone item without a clinical question rarely helps, because nobody has agreed in advance what the result will be compared against.

If you are planning care in China, the sensible route is a specialist consultation in hepatology, gastroenterology or oncology, depending on your history. The clinician decides whether AFP is appropriate, which other tests or imaging are needed, and how the results fit together. A coordinator can help arrange the appointment and interpretation support, but the clinical judgement belongs to the treating doctor.

If you already have a diagnosis or an abnormal result from your home country, bring the original reports rather than a summary. The reviewing team will want to see dates, units, reference ranges and any imaging reports, because these determine whether a repeat test in China is meaningful or unnecessary.

Digestive disease care in China

Records that make a review useful

A clinician reviewing an AFP result remotely or in person works from documents. The most useful set is usually compact: the AFP report itself with the laboratory's reference range, any earlier AFP results with dates, liver function and hepatitis B or C test results, and imaging reports such as ultrasound, CT or MRI. Pathology reports matter if a liver lesion has already been sampled.

A short written summary of your history helps too: when liver problems were first noted, whether you have known hepatitis or cirrhosis, current medicines, and the specific question you want answered. You do not need to send a complete medical archive at first contact. A brief summary lets the team identify what is missing before any appointment is arranged.

Ask the receiving clinician which documents they need in original form and which can be copies or translations. Requirements differ between hospitals, and it is better to confirm than to assume. If a report is in another language, ask whether a certified translation is expected before the consultation.

Practical questions before you arrange testing in China

The logistics of a blood test are simple; the decisions around it are not. Before travelling or booking, clarify with the hospital or your coordination contact how the test fits into a wider assessment. A stand-alone diagnostic test normally needs a clinician's order, and the hospital decides what it will accept and how it will report.

It is reasonable to ask whether the result will be discussed with you by the ordering clinician, in what language, and whether a written interpretation is provided. Ask what the fee covers and whether the consultation, the laboratory test and any imaging are quoted separately. These are questions about this provider's written scope, not assumptions about how Chinese hospitals bill in general.

If your reason for testing is a known liver condition, ask whether the visit should include imaging on the same trip or whether results from home are sufficient. The answer depends on your case, and the treating team should make that call rather than a template itinerary.

  • Which clinician will order the AFP test, and what clinical question is it answering?
  • Which earlier results and imaging reports should be sent before the appointment?
  • Is an English-language report or interpretation available, and who explains it?
  • What does the written quote include, and which items are charged separately?

What the result does and does not change

An AFP result is one piece of evidence. It may support a clinician's assessment, prompt further imaging, or contribute to monitoring over time. It does not by itself confirm a diagnosis, rule one out, or determine treatment. Decisions about further tests, surveillance intervals or treatment belong to the treating team and depend on the full picture.

If a result is unexpected, the priority is a conversation with a qualified clinician who can see your other records, not a search for a second number online. Worsening symptoms such as new abdominal pain, jaundice or unexplained weight loss need prompt local medical assessment rather than waiting for an overseas appointment.

For patients considering care in China, the realistic next step is a short initial enquiry describing your situation and main question. The team can indicate what information is missing and which specialist route may fit. That enquiry is not a diagnosis, and hospital acceptance and clinical suitability remain decisions for the treating hospital.

Sources & scope of this guide

References and official service information relevant to this guide.

  1. oncology
  2. Digestive disease care in China
  3. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/alpha-fetoprotein
  4. https://www.nhs.uk/conditions/liver-cancer/diagnosis/

This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.